239 related articles for article (PubMed ID: 19039757)
61. [Cardiovascular risk in diabetes--diagnostic and therapeutic aspects].
Schnell O; Standl E
MMW Fortschr Med; 2004 Sep; 146(35-36):36-8. PubMed ID: 15540537
[TBL] [Abstract][Full Text] [Related]
62. Optimal Antiplatelet Therapy in ST-Segment Elevation Myocardial Infarction.
Harari R; Baber U
Interv Cardiol Clin; 2016 Oct; 5(4):481-495. PubMed ID: 28581997
[TBL] [Abstract][Full Text] [Related]
63. Mitral stenosis as a risk factor for embolic myocardial infarction--anticoagulation for some patients, individual treatment for all.
Liang M; Kelly D; Puri A; Devlin G
Heart Lung Circ; 2011 Nov; 20(11):728-30. PubMed ID: 21459673
[TBL] [Abstract][Full Text] [Related]
64. Thrombin generation and platelet reactivity at hospital discharge and 6-month outcome after the acute coronary syndrome in diabetic and nondiabetic patients.
Kuliczkowski W; Szewczyk M; Kaczmarski J; Sztohryn E; Greif M; Pres D; Fortmann SD; Poloński L; Serebruany V
Cardiology; 2014; 128(1):25-33. PubMed ID: 24514756
[TBL] [Abstract][Full Text] [Related]
65. Cocaine-induced myocardial infarction: not your average acute coronary syndrome.
Behar JM; Lindsay AC; McEwan JR
Br J Hosp Med (Lond); 2009 Feb; 70(2):108-9. PubMed ID: 19229154
[No Abstract] [Full Text] [Related]
66. Timing of anti-platelet effect after oral aspirin administration in patients with sympathetic excitement.
Nishiyama A; Niikawa O; Mohri H; Tsushima M
Circ J; 2003 Aug; 67(8):697-700. PubMed ID: 12890913
[TBL] [Abstract][Full Text] [Related]
67. Effect of Bruton's tyrosine kinase inhibitors on platelet aggregation in patients with acute myocardial infarction.
Bhatti M; Ayton S; Michail O; Gollop ND; Ryding A; Rushworth S; Bowles K; Geisler T; Flather M
Thromb Res; 2019 Jul; 179():64-68. PubMed ID: 31082751
[TBL] [Abstract][Full Text] [Related]
68. Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.
Gurbel PA; Tantry US; D'Andrea D; Chung T; Alexander JH; Bliden KP; Wright SD; Tricoci P
J Thromb Thrombolysis; 2018 May; 45(4):469-476. PubMed ID: 29582212
[TBL] [Abstract][Full Text] [Related]
69. Spinal cord transient ischemic attacks: a possible role for abciximab.
Hussain MS; Shuaib A; Siddiqi ZA
Neurology; 2005 Feb; 64(4):761-2. PubMed ID: 15728318
[No Abstract] [Full Text] [Related]
70. Antiplatelet therapy in STEMI undergoing primary PCI: when, which one and how long.
Baralis G; Rossini R; Musumeci G
Minerva Cardioangiol; 2018 Aug; 66(4):422-428. PubMed ID: 29458246
[TBL] [Abstract][Full Text] [Related]
71. [Experience of treatment of patients with myocardial infarction without raise of ST segment on ECG of high risk of cardiocomplications by method of coronary angioplasty].
Shames AB; Igonin VA; Krashutskiĭ VV; Ivanov VA; Terekhin SA
Voen Med Zh; 2010 Jan; 331(1):35-9. PubMed ID: 20536036
[TBL] [Abstract][Full Text] [Related]
72. [Effect of ivabradin and clopidogrel on platelet hemostasis indices in patients with acute coronary syndrome without ST-segment elevation and with concurrent cardiac insufficiency].
Miziuk VM
Lik Sprava; 2008; (3-4):71-5. PubMed ID: 19145824
[TBL] [Abstract][Full Text] [Related]
73. Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarction.
Gurbel PA; Kereiakes DJ; Atar D; Serebruany VL
Scand Cardiovasc J; 2000; 34(1):53-8. PubMed ID: 10816061
[TBL] [Abstract][Full Text] [Related]
74. Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing.
Komiya T; Kudo M; Urabe T; Mizuno Y
Stroke; 1994 Dec; 25(12):2337-42. PubMed ID: 7974570
[TBL] [Abstract][Full Text] [Related]
75. Nonbacterial thrombotic endocarditis with ST-elevation myocardial infarction treated with percutaneous coronary aspiration thrombectomy.
Tiong IS; Williams MJ; Perez DJ
Heart Lung Circ; 2013 May; 22(5):386-9. PubMed ID: 23219311
[TBL] [Abstract][Full Text] [Related]
76. In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus.
Böhm A; Lauko V; Dostalova K; Balanova I; Varga I; Bezak B; Jajcay N; Moravcik R; Lazurova L; Slezak P; Mojto V; Kollarova M; Petrikova K; Danova K; Zeman M
J Endocrinol Invest; 2023 Dec; 46(12):2493-2500. PubMed ID: 37148530
[TBL] [Abstract][Full Text] [Related]
77. Posterior wall myocardial infarction.
Brown DF; Nadel ES
J Emerg Med; 2004 Jul; 27(1):75-8. PubMed ID: 15219307
[No Abstract] [Full Text] [Related]
78. Immature platelets and platelet reactivity in patients with acute ST-segment Elevation Myocardial Infarction using whole blood flow cytometry with SYTO-13 staining.
Pedersen OB; Hvas AM; Nissen PH; Pasalic L; Kristensen SD; Grove EL
Thromb Res; 2024 May; 237():100-107. PubMed ID: 38579511
[TBL] [Abstract][Full Text] [Related]
79. Clopidogrel use in ST-elevation myocardial infarction (STEMI).
Yiadom MY
J Emerg Med; 2010 Aug; 39(2):217-8. PubMed ID: 19168312
[No Abstract] [Full Text] [Related]
80. Correlation of platelet count and acute ST-elevation in myocardial infarction.
Paul GK; Sen B; Bari MA; Rahman Z; Jamal F; Bari MS; Sazidur SR
Mymensingh Med J; 2010 Jul; 19(3):469-73. PubMed ID: 20639847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
